1. Show article details.

    Intermolecular to Report First Quarter 2014 Financial Results on May 6, 2014

    GlobeNewswire – 4:10 PM ET 04/18/2014

    Intermolecular, Inc. (IMI) today announced it will release financial results for the fiscal first quarter ended March 31, 2014 after the U.S. financial markets close on Tuesday, May 6, 2014. To participate via telephone, the toll free dial-in number is 251-1860; international callers should dial 357-2386.

  2. Show article details.

    MARKET PULSE-CME, NII Holdings, Tumi, E-Commerce China, Pier Imports

    Reuters – 3:48 PM ET 02/28/2014

    U.S. stocks rose on Friday as some positive economic data boosted the S&P 500 to record levels for a second straight day and put major indexes on track for strong gains in both the week and the month. ** CENTRAL EUROPEAN MEDIA ENTERPRISES (CETV), $4.655, +71.77 pct.

  3. Show article details.

    MARKET PULSE-NII Holdings, CME, Intermolecular, Varonis, Medivation

    Reuters – 1:20 PM ET 02/28/2014

    U.S. stocks rose on Friday as some positive economic data boosted the S&P 500 to record levels for a second straight day and put major indexes on track for strong gains in both the week and the month. ** CENTRAL EUROPEAN MEDIA ENTERPRISES (CETV), $4.68, +72.69 pct.

  4. Show article details.

    Intermolecular Announces New Developments in the SanDisk/Toshiba Relationship

    GlobeNewswire – 4:31 PM ET 02/27/2014

    Intermolecular, Inc.—accelerating research and development for semiconductor and clean energy industries—today announced that the development activity related to the Collaborative Development Program agreement with SanDisk and Toshiba has reached its successful conclusion.

  5. Show article details.

    Intermolecular(R) and Guardian Industries Expand Collaboration and Strategic IP Licensing Agreement

    GlobeNewswire – 8:30 AM ET 02/11/2014

    Intermolecular, Inc. (IMI) and Guardian Industries announced today the expansion and extension of their collaborative development program and strategic IP licensing agreement.

  6. Show article details.

    Intermolecular Announces Full Year and Fourth Quarter 2013 Results

    GlobeNewswire – 4:10 PM ET 02/06/2014

    Intermolecular, Inc.-accelerating research and development for semiconductor and clean energy industries-today announced results for its full year and fourth quarter ended December 31, 2013. Full Year 2013 Results For the year ended December 31, 2013, revenue was $67.4 million compared to revenue of $66.8 million in 2012.

  7. Show article details.

    Intermolecular to Report Fourth Quarter and FY2013 Financial Results on February 6, 2014

    GlobeNewswire – 4:10 PM ET 01/23/2014

    Intermolecular, Inc.—accelerating research and development for semiconductor and clean energy industries—today announced it will release financial results for the fiscal fourth quarter ended December 31, 2013 and fiscal year 2013 after the U.S. financial markets close on Thursday, February 6, 2014.

  8. Show article details.

    Intermolecular to Present at Financial Events in First Quarter 2014

    GlobeNewswire – 4:10 PM ET 01/06/2014

    Intermolecular, Inc.—accelerating research and development for semiconductor and clean energy industries—today announced that the company will present at the following investor conferences during the first quarter of 2014: About Intermolecular, Inc. Intermolecular® has pioneered a proprietary approach to accelerate research and development, innovation, and time-to-market for the semiconduc...

  9. Show article details.

    Intermolecular Announces Third Quarter 2013 Financial Results

    GlobeNewswire – 4:10 PM ET 10/24/2013

    Intermolecular, Inc. (IMI) - accelerating research and development for semiconductor and clean energy industries - today announced results for its third quarter ended September 30, 2013. Revenue for the third quarter of 2013 was $17.7 million, representing year-over-year growth of 8% from $16.5 million in the third quarter of 2012.

Page:

Today's and Upcoming Events

  • May
    6

    IMI to announce Q1 earnings After Market (Confirmed)

  • May
    6

    IMI Earnings Conference Call at 4:30 PM Listen

Past Events (last 90 days)

No events in the past 90 days

Data provided by Wall Street Horizon, Inc. © 2014

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.